EODData

MEMBERSHIP REGISTER LOG IN

NSE, GLAXO: GlaxoSmithKline Pharmaceuticals Limited

21 Nov 2025
LAST:

2,498

CHANGE:
 11.10		OPEN:
2,501		HIGH:
2,523		ASK:
0		VOLUME:
72.3K
CHG(%):
0.44		PREV:
2,509		LOW:
2,488		BID:
0		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
21 Nov 252,5012,5232,4882,49872.3K
20 Nov 252,5152,5332,5012,50931.6K
19 Nov 252,4902,5262,4712,51953.3K
18 Nov 252,5052,5052,4812,48868.4K
17 Nov 252,4922,5252,4752,493174.5K
14 Nov 252,5002,5152,4712,47951.4K
13 Nov 252,5072,5482,4862,49561.5K
12 Nov 252,4862,5372,4732,507123.1K
11 Nov 252,5482,5512,4682,476255.7K
10 Nov 252,5872,5912,5342,54059.2K

PROFILE

Name:GlaxoSmithKline Pharmaceuticals Limited
About:GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers vaccines, such as Infanrix Hexa for vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and disease caused by Haemophilus influenzae type B; Synflorix for active immunization of infants against pneumococcal diseases and acute otitis media; Havrix for active immunization against disease caused by Hepatitis A virus; Menveo to prevent invasive meningococcal disease; Boostrix for immunization against diphtheria, tetanus and pertussis; Fluarix Tetra for the prevention of influenza disease; Varilrix for active immunization against varicella; and Shingrix for prevention of herpes zoster and post-herpetic neuralgia. It also provides specialty medicines, such as NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; and Trelegy Ellipta for treating chronic obstructive pulmonary disease. In addition, the company offers general medicines, including AUGMENTIN and CEFTUM, an oral antibiotic to treat bacterial infections; CobadexCZS to treat mineral and vitamins deficiency states in adult patients; Flutivate, a skin cream for adults, children and infants; Tenovate to treat inflammatory and pruritic manifestations of steroid responsive dermatosis; CALPOL to treat mild to moderate pain; ELTROXIN for hypothyroidism; CCM to treat calcium and vitamin D deficiency; NEOSPORIN for treatment of specific bacterial skin infections; BETNOVATE for skin conditions; T-BACT for bacterial skin infections; and PHYSIOGEL for dry skin associated with redness and itch. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is based in Mumbai, India.
Sector:Healthcare
Address:GSK House, Mumbai, India, 400030
Website:https://india-pharma.gsk.com
ISIN:INE159A01016

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:47.41 
Forward P/E:45.92 
PEG Ratio:3.81 
Price to Sales:12.04 
Price to Book:23.08 
Profit Margin:0.25 
Operating Margin:0.29 
Return on Assets:0.23 
Return on Equity:0.48 
Revenue:37.397B 
EBITDA:12.839B 
Shares:169.41M 
Market Cap:423.159B 

TECHNICAL INDICATORS

MA5:2,501.380.1%
MA10:2,500.360.1%
MA20:2,576.233.1%
MA50:2,677.817.2%
MA100:2,831.9713.4%
MA200:2,881.8715.4%
STO9:29.03
STO14:9.92 
RSI14:34.89 
WPR14:-89.54 
MTM14:-184.90
ROC14:-0.07 
ATR:62.17 
Week High:2,532.601.4%
Week Low:2,470.901.1%
Month High:2,795.9011.9%
Month Low:2,467.5015.4%
Year High:3,515.7040.7%
Year Low:1,921.0030.0%
Volatility:3.45 

RECENT SPLITS

Date Ratio
11 Sep 20182-1

RECENT DIVIDENDS

Date Amount
30 May 2025$42.00
07 Nov 2024$12.00
31 May 2024$32.00
30 Jun 2023$32.00
07 Jul 2022$90.00
19 Jul 2021$30.00
17 Jul 2020$40.00
11 Jul 2019$20.00
13 Jul 2018$8.75
14 Jul 2017$7.50